X-Zell

X-ZELL is a global startup focused on pioneering rare cell detection technology for early and pain-free cancer detection. Supported by Y Combinator and prominent angel investors, including Gmail's creator Paul Buchheit, X-ZELL has created a groundbreaking platform for isolating and visualizing rare and abnormal cells, such as Circulating Endothelial Cells (CEC). Their comprehensive platform encompasses blood processing, cell analysis, and reporting, all executed in-house using patented and proprietary technology. By integrating established pathological research with their advanced technology, X-ZELL delivers reliable results and broad clinical utility, spanning research, medication management, companion diagnostics, relapse control, and diagnostic decision-making.